Transcode Therapeutics Retains Advisor for Strategic Process
Transcode Therapeutics retained Tungsten Advisors to lead a formal strategic process intended to maximize value of TTX-MC138 and its oncology portfolio.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
TransCode Therapeutics Retains Advisors for Strategic Process
TransCode Therapeutics retained Tungsten Advisors to lead a formal strategic process intended to maximize value of TTX-MC138 and its oncology portfolio.
TransCode Therapeutics Hires Adviser for Strategic Process
TransCode Therapeutics retained Tungsten Advisors to lead a strategic process intended to maximize value of TTX-MC138 and its oncology portfolio.